GITNUXREPORT 2025

Crps Statistics

CRPS affects over 26 per 100,000, mainly women, with persistent severe pain.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

CRPS affects approximately 5.4 per 100,000 people worldwide

Statistic 2

The average duration of CRPS symptoms before diagnosis is about 12 to 24 months

Statistic 3

CRPS is more common in women, accounting for about 70% of cases

Statistic 4

The median age of CRPS onset is around 40 years

Statistic 5

Approximately 60% of CRPS cases follow trauma or injury

Statistic 6

The estimated annual incidence of CRPS is roughly 26.2 per 100,000 person-years in the US

Statistic 7

CRPS type I accounts for about 90% of cases

Statistic 8

The condition can occur in any limb but is most common in the lower extremities

Statistic 9

Osteoporosis can develop as a secondary complication in CRPS patients, affecting about 31% of chronic cases

Statistic 10

Approximately 30% of patients with CRPS experience persistent symptoms for more than 2 years

Statistic 11

CRPS has a reported prevalence of 26 per 100,000 in the general population

Statistic 12

CRPS can occur at any age but is most typically diagnosed in middle-aged adults

Statistic 13

Women under 50 are at a higher risk of developing CRPS, particularly after injury

Statistic 14

The prevalence of CRPS following wrist fracture is approximately 15-20%, making it a common complication

Statistic 15

Approximately 25% of people with CRPS have co-existing psychiatric conditions, including depression or post-traumatic stress disorder

Statistic 16

The incidence of CRPS after minimally invasive procedures like injections or surgeries is relatively low, around 1-2%, but still significant

Statistic 17

The majority of CRPS cases involve the extremities, with upper limb CRPS accounting for 60-70% of cases

Statistic 18

Women are approximately twice as likely as men to develop CRPS after injury, indicating gender disparity in susceptibility

Statistic 19

The probability of developing CRPS after limb surgery is about 2-5%, depending on surgical type and patient risk factors

Statistic 20

The rate of CRPS diagnosis in pediatric populations is significantly lower, at about 1-2 per 100,000 children

Statistic 21

The main symptoms include severe pain, swelling, and changes in skin temperature and color

Statistic 22

CRPS is diagnosed primarily based on clinical criteria, with no definitive test

Statistic 23

Neuroplastic changes are evident in the brains of CRPS patients, with altered somatosensory processing

Statistic 24

There is a genetic predisposition component believed to influence CRPS susceptibility, though specifics are still under research

Statistic 25

CRPS can lead to disuse atrophy due to prolonged immobilization or pain-avoidance behaviors, affecting muscle mass

Statistic 26

CRPS is frequently associated with abnormal autonomic nervous system activity, such as changes in sweating or skin temperature, in about 80% of cases

Statistic 27

The pain intensity in CRPS is often rated as 7 or higher on a 10-point scale, even in chronic stages

Statistic 28

CRPS can involve trophic changes such as hair and nail growth abnormalities, noted in about 40-50% of patients

Statistic 29

Approximately 80% of CRPS cases show signs of autonomic dysregulation, including abnormal sweating patterns

Statistic 30

Chronic CRPS is associated with increased levels of pro-inflammatory cytokines in affected limb tissues, indicating inflammation's role in persistence

Statistic 31

Psychological factors such as depression and anxiety are present in approximately 40% of CRPS patients

Statistic 32

about 65% of CRPS patients report that their quality of life is significantly impaired

Statistic 33

CRPS symptoms can be exacerbated by stress or emotional distress, affecting about 50% of patients

Statistic 34

About 15-20% of CRPS patients develop psychological comorbidities over time, further complicating treatment

Statistic 35

Early diagnosis of CRPS improves treatment outcomes significantly

Statistic 36

The use of sympathetic nerve blocks can reduce pain in about 74% of CRPS patients

Statistic 37

Mirror therapy has shown improvement in motor function in up to 80% of persistent CRPS cases

Statistic 38

The average reduction in pain after physical therapy is about 50%

Statistic 39

The use of bisphosphonates has been associated with pain improvement in about 55% of CRPS cases

Statistic 40

The use of spinal cord stimulation improves pain scores in roughly 70% of chronic CRPS patients

Statistic 41

The condition is often refractory to treatment, with only about 20-40% of patients achieving complete relief

Statistic 42

The economic burden of CRPS, including healthcare costs, can exceed $24,000 per patient annually

Statistic 43

The success rate of nerve block interventions varies from 40% to 80%, depending on timing and technique

Statistic 44

Cognitive-behavioral therapy (CBT) can help improve coping strategies in about 60-70% of CRPS patients

Statistic 45

The use of graded motor imagery can result in pain reduction in roughly 60-70% of CRPS patients

Statistic 46

Early physical therapy intervention can reduce long-term disability in CRPS by up to 50%

Statistic 47

The use of vitamin C has been shown to decrease the incidence of CRPS after wrist fractures by about 50%

Statistic 48

The use of topical medications such as capsaicin can help reduce localized pain in some CRPS patients, with about 30-40% experiencing relief

Statistic 49

CRPS patients report an average of 60-80% reduction in pain severity after multidisciplinary treatment approaches

Statistic 50

Functional improvements in CRPS patients are observed in approximately 50-60% following comprehensive therapy

Statistic 51

The use of antidepressants and anticonvulsants has provided pain relief in roughly 50% of CRPS cases, especially in neuropathic pain components

Slide 1 of 51

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

CRPS affects approximately 5.4 per 100,000 people worldwide
The average duration of CRPS symptoms before diagnosis is about 12 to 24 months
CRPS is more common in women, accounting for about 70% of cases
The median age of CRPS onset is around 40 years
Approximately 60% of CRPS cases follow trauma or injury
The estimated annual incidence of CRPS is roughly 26.2 per 100,000 person-years in the US
CRPS type I accounts for about 90% of cases
The condition can occur in any limb but is most common in the lower extremities
The main symptoms include severe pain, swelling, and changes in skin temperature and color
Early diagnosis of CRPS improves treatment outcomes significantly
Osteoporosis can develop as a secondary complication in CRPS patients, affecting about 31% of chronic cases
The use of sympathetic nerve blocks can reduce pain in about 74% of CRPS patients
Mirror therapy has shown improvement in motor function in up to 80% of persistent CRPS cases

Did you know that Complex Regional Pain Syndrome (CRPS) affects approximately 5.4 per 100,000 people worldwide, often following injury and predominantly impacting middle-aged women, yet early diagnosis and multidisciplinary treatments can significantly improve outcomes for those affected?

Epidemiology and Prevalence

CRPS affects approximately 5.4 per 100,000 people worldwide
The average duration of CRPS symptoms before diagnosis is about 12 to 24 months
CRPS is more common in women, accounting for about 70% of cases
The median age of CRPS onset is around 40 years
Approximately 60% of CRPS cases follow trauma or injury
The estimated annual incidence of CRPS is roughly 26.2 per 100,000 person-years in the US
CRPS type I accounts for about 90% of cases
The condition can occur in any limb but is most common in the lower extremities
Osteoporosis can develop as a secondary complication in CRPS patients, affecting about 31% of chronic cases
Approximately 30% of patients with CRPS experience persistent symptoms for more than 2 years
CRPS has a reported prevalence of 26 per 100,000 in the general population
CRPS can occur at any age but is most typically diagnosed in middle-aged adults
Women under 50 are at a higher risk of developing CRPS, particularly after injury
The prevalence of CRPS following wrist fracture is approximately 15-20%, making it a common complication
Approximately 25% of people with CRPS have co-existing psychiatric conditions, including depression or post-traumatic stress disorder
The incidence of CRPS after minimally invasive procedures like injections or surgeries is relatively low, around 1-2%, but still significant
The majority of CRPS cases involve the extremities, with upper limb CRPS accounting for 60-70% of cases
Women are approximately twice as likely as men to develop CRPS after injury, indicating gender disparity in susceptibility
The probability of developing CRPS after limb surgery is about 2-5%, depending on surgical type and patient risk factors
The rate of CRPS diagnosis in pediatric populations is significantly lower, at about 1-2 per 100,000 children

Epidemiology and Prevalence Interpretation

While CRPS is a rare yet serious condition affecting roughly 5.4 per 100,000 globally—most commonly in women around 40 years old following injury—its insidious 12 to 24-month delay in diagnosis and potential for long-term impairment underscore the urgent need for heightened awareness and timely intervention in both clinical and public health domains.

Pathophysiology and Clinical Features

The main symptoms include severe pain, swelling, and changes in skin temperature and color
CRPS is diagnosed primarily based on clinical criteria, with no definitive test
Neuroplastic changes are evident in the brains of CRPS patients, with altered somatosensory processing
There is a genetic predisposition component believed to influence CRPS susceptibility, though specifics are still under research
CRPS can lead to disuse atrophy due to prolonged immobilization or pain-avoidance behaviors, affecting muscle mass
CRPS is frequently associated with abnormal autonomic nervous system activity, such as changes in sweating or skin temperature, in about 80% of cases
The pain intensity in CRPS is often rated as 7 or higher on a 10-point scale, even in chronic stages
CRPS can involve trophic changes such as hair and nail growth abnormalities, noted in about 40-50% of patients
Approximately 80% of CRPS cases show signs of autonomic dysregulation, including abnormal sweating patterns
Chronic CRPS is associated with increased levels of pro-inflammatory cytokines in affected limb tissues, indicating inflammation's role in persistence

Pathophysiology and Clinical Features Interpretation

CRPS's complex web of severe pain, autonomic dysfunction, neuroplastic brain changes, and inflammatory processes underscores why accurate diagnosis remains elusive and underscores the urgent need for targeted therapies beyond symptom management.

Psychosocial and Quality of Life Aspects

Psychological factors such as depression and anxiety are present in approximately 40% of CRPS patients
about 65% of CRPS patients report that their quality of life is significantly impaired
CRPS symptoms can be exacerbated by stress or emotional distress, affecting about 50% of patients
About 15-20% of CRPS patients develop psychological comorbidities over time, further complicating treatment

Psychosocial and Quality of Life Aspects Interpretation

Complex Regional Pain Syndrome not only inflicts relentless physical agony but also weaves a psychological web—affecting nearly two-thirds of patients’ quality of life, with depression and anxiety lurking as both cause and consequence in this intricate pain puzzle.

Treatment and Management

Early diagnosis of CRPS improves treatment outcomes significantly
The use of sympathetic nerve blocks can reduce pain in about 74% of CRPS patients
Mirror therapy has shown improvement in motor function in up to 80% of persistent CRPS cases
The average reduction in pain after physical therapy is about 50%
The use of bisphosphonates has been associated with pain improvement in about 55% of CRPS cases
The use of spinal cord stimulation improves pain scores in roughly 70% of chronic CRPS patients
The condition is often refractory to treatment, with only about 20-40% of patients achieving complete relief
The economic burden of CRPS, including healthcare costs, can exceed $24,000 per patient annually
The success rate of nerve block interventions varies from 40% to 80%, depending on timing and technique
Cognitive-behavioral therapy (CBT) can help improve coping strategies in about 60-70% of CRPS patients
The use of graded motor imagery can result in pain reduction in roughly 60-70% of CRPS patients
Early physical therapy intervention can reduce long-term disability in CRPS by up to 50%
The use of vitamin C has been shown to decrease the incidence of CRPS after wrist fractures by about 50%
The use of topical medications such as capsaicin can help reduce localized pain in some CRPS patients, with about 30-40% experiencing relief
CRPS patients report an average of 60-80% reduction in pain severity after multidisciplinary treatment approaches
Functional improvements in CRPS patients are observed in approximately 50-60% following comprehensive therapy
The use of antidepressants and anticonvulsants has provided pain relief in roughly 50% of CRPS cases, especially in neuropathic pain components

Treatment and Management Interpretation

While early diagnosis and multifaceted treatments can significantly alleviate CRPS's grip, the condition's stubborn resistance and hefty price tag remind us that the path to relief is often as complex as the syndrome itself.